Cargando…
Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
Recent studies have demonstrated significant molecular parallels between atopic dermatitis and alopecia areata as predominantly TH2‐mediated diseases. This case report highlights the potential for Dupilumab as a targeted biologic therapy in both atopic dermatitis and alopecia areata.
Autores principales: | Call, John E., Sahni, Sakshi, Zug, Kathryn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455431/ https://www.ncbi.nlm.nih.gov/pubmed/32884748 http://dx.doi.org/10.1002/ccr3.2915 |
Ejemplares similares
-
Improvement of atopic dermatitis and alopecia universalis with dupilumab
por: Alotaibi, Lama, et al.
Publicado: (2021) -
Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
por: Alniemi, Dema T., et al.
Publicado: (2019) -
Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab
por: Smogorzewski, Jan, et al.
Publicado: (2019) -
Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021) -
A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
por: Zhao, Jiahui, et al.
Publicado: (2022)